Literature DB >> 27669735

Bone Densitometry in Children and Adolescents.

Laura K Bachrach, Catherine M Gordon.   

Abstract

Concerns about bone health and potential fragility in children and adolescents have led to a high interest in bone densitometry. Pediatric patients with genetic and acquired chronic diseases, immobility, and inadequate nutrition may fail to achieve expected gains in bone size, mass, and strength, leaving them vulnerable to fracture. In older adults, bone densitometry has been shown to predict fracture risk and reflect response to therapy. The role of densitometry in the management of children at risk of bone fragility is less clear. This clinical report summarizes current knowledge about bone densitometry in the pediatric population, including indications for its use, interpretation of results, and risks and costs. The report emphasizes updated consensus statements generated at the 2013 Pediatric Position Development Conference of the International Society of Clinical Densitometry by an international panel of bone experts. Some of these recommendations are evidence-based, whereas others reflect expert opinion, because data are sparse on many topics. The statements from this and other expert panels provide general guidance to the pediatrician, but decisions about ordering and interpreting bone densitometry still require clinical judgment. The interpretation of bone densitometry results in children differs from that in older adults. The terms "osteopenia" and "osteoporosis" based on bone densitometry findings alone should not be used in younger patients; instead, bone mineral content or density that falls >2 SDs below expected is labeled "low for age." Pediatric osteoporosis is defined by the Pediatric Position Development Conference by using 1 of the following criteria: ≥1 vertebral fractures occurring in the absence of local disease or high-energy trauma (without or with densitometry measurements) or low bone density for age and a significant fracture history (defined as ≥2 long bone fractures before 10 years of age or ≥3 long bone fractures before 19 years of age). Ongoing research will help define the indications and best methods for assessing bone strength in children and the clinical factors that contribute to fracture risk. The Pediatric Endocrine Society affirms the educational value of this publication.
Copyright © 2016 by the American Academy of Pediatrics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27669735     DOI: 10.1542/peds.2016-2398

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  13 in total

Review 1.  [Fractures and bone mineral density in childhood].

Authors:  Christine Hofmann; Herrmann Girschick; Constantin Lapa; Oliver Semler; Franz Jakob
Journal:  Z Rheumatol       Date:  2019-09       Impact factor: 1.372

2.  Lumbar Spine Bone Mineral Apparent Density in Children: Results From the Bone Mineral Density in Childhood Study.

Authors:  Joseph M Kindler; Joan M Lappe; Vicente Gilsanz; Sharon Oberfield; John A Shepherd; Andrea Kelly; Karen K Winer; Heidi J Kalkwarf; Babette S Zemel
Journal:  J Clin Endocrinol Metab       Date:  2019-04-01       Impact factor: 5.958

Review 3.  Dual-energy X-ray absorptiometry bone densitometry in pediatrics: a practical review and update.

Authors:  Hedieh Khalatbari; Larry A Binkovitz; Marguerite T Parisi
Journal:  Pediatr Radiol       Date:  2020-08-28

Review 4.  Pediatric Osteoporosis: Diagnosis and Treatment Considerations.

Authors:  Edoardo Marrani; Teresa Giani; Gabriele Simonini; Rolando Cimaz
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

Review 5.  Impact of gender-affirming treatment on bone health in transgender and gender diverse youth.

Authors:  Silvia Ciancia; Vanessa Dubois; Martine Cools
Journal:  Endocr Connect       Date:  2022-09-28       Impact factor: 3.221

6.  Bone mineral density reference standards for Chinese children aged 3-18: cross-sectional results of the 2013-2015 China Child and Adolescent Cardiovascular Health (CCACH) Study.

Authors:  Junting Liu; Liang Wang; Jinghui Sun; Gongshu Liu; Weili Yan; Bo Xi; Feng Xiong; Wenqing Ding; Guimin Huang; Steven Heymsfield; Jie Mi
Journal:  BMJ Open       Date:  2017-05-29       Impact factor: 2.692

7.  Osteoporosis Therapy: Bone Modeling during Growth and Aging.

Authors:  Toshihiro Sugiyama; Hiromi Oda
Journal:  Front Endocrinol (Lausanne)       Date:  2017-03-09       Impact factor: 5.555

8.  pQCT bone geometry and strength: population epidemiology and concordance in Australian children aged 11-12 years and their parents.

Authors:  Jennifer Vlok; Peter J Simm; Kate Lycett; Susan A Clifford; Anneke C Grobler; Katherine Lange; Najmi Ismail; William Osborn; Melissa Wake
Journal:  BMJ Open       Date:  2019-07-04       Impact factor: 2.692

9.  Deficits in Bone Geometry in Growth Hormone-Deficient Prepubertal Boys Revealed by High-Resolution Peripheral Quantitative Computed Tomography.

Authors:  Tamar G Baer; Sanchita Agarwal; Shaoxuan Chen; Codruta Chiuzan; Aviva B Sopher; Rachel Tao; Abeer Hassoun; Elizabeth Shane; Ilene Fennoy; Sharon E Oberfield; Patricia M Vuguin
Journal:  Horm Res Paediatr       Date:  2020-03-30       Impact factor: 2.852

10.  Evaluation of bone mineral status in prepuberal children with newly diagnosed type 1 diabetes.

Authors:  Jung Gi Roh; Jong Seo Yoon; Kyu Jung Park; Jung Sub Lim; Hae Sang Lee; Jin Soon Hwang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2018-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.